Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host adaptive immune receptors, specifically T-cell receptors (TCRs) and B-cell receptors (BCRs), are the primary molecular components of the avian immune system that recognize antigens expressed by the Herpesvirus of Turkeys (HVT) vector [1]. HVT is a non-pathogenic alphaherpesvirus used globally as a live vaccine vector to deliver protective antigens from Marek’s Disease Virus (MDV) and other poultry pathogens [2]. These receptors function by binding to specific viral epitopes; BCRs recognize native protein structures to initiate antibody production, while TCRs recognize processed peptides presented by Major Histocompatibility Complex (MHC) molecules to trigger cellular immunity [3]. The interaction between these receptors and HVT-expressed antigens, such as glycoprotein B (gB), is critical for establishing protective immunity against Marek's Disease, a highly contagious lymphoproliferative disorder [4]. In the poultry industry, these receptors are the functional targets of recombinant HVT (rHVT) vaccines, which are engineered to elicit robust, lifelong protection without the virulence of wild-type MDV [5]. Understanding the specificity and activation thresholds of these receptors is essential for optimizing vaccine efficacy and overcoming challenges like maternal antibody interference [6].
Activation of host T and B cells through the recognition of HVT-expressed viral antigens presented by MHC molecules, leading to protective immunity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Host adaptive immune receptors (T-cell receptor and B-cell receptor) (TCR/BCR).